38 Stocks Moving In Friday's Mid-Day Session

Gainers

  • Greenland Acquisition Corporation GLAC shares jumped 47.7% to $10.31. Greenland Acquisition reported adjournment of special meeting of shareholders to approve proposed business combination with Zhongchai Holding (Hong Kong) Limited.
  • Attis Industries, Inc. ATIS shares climbed 47.3% to $1.9584 after climbing 37.11% on Thursday.
  • Dermira, Inc. DERM surged 33% to $7.57 after the company presented data from Phase 2b study of lebrikizumab in patients with atopic dermatitis at he 39th Annual Fall Clinical Dermatology Conference in Las Vegas.
  • Ideal Power Inc. IPWR shares gained 11.6% to $2.59 after the company sold its Power Conversion Systems business and Power Packet Switching Architecture technology to CE+T Energy Solutions, Inc.
  • Ruhnn Holding Limited RUHN climbed 10.2% to $4.95.
  • Fluidigm Corporation FLDM shares rose 9.5% to $4.72 after UBS upgraded the company's stock from Neutral to Buy.
  • Sienna Biopharmaceuticals, Inc. SNNA gained 8.1% to $0.1730 as a potential rebound after the stock fell roughly 43% since October 7.
  • Ring Energy, Inc. REI fell 8% to $1.72 after surging 13.33% on Thursday.
  • Borr Drilling Limited BORR shares rose 7.7% to $6.45.
  • Quotient Limited QTNT climbed 7.7% to $8.54.
  • Contango Oil & Gas Company MCF shares climbed 7.7% to $2.3359. Contango named John Goff as new Chairman of the board.
  • Datasea Inc. DTSS shares gained 7.5% to $2.2564.
  • Provention Bio, Inc.PRVB rose 7.1% to $6.45.
  • Ballard Power Systems Inc. BLDP rose 6.6% to $5.63.
  • Kansas City Southern KSU gained 5.2% to $142.50 after the company reported better-than-expected Q3 EPS and sales results.
  • RedHill Biopharma Ltd. RDHL rose 5.2% to $6.49 after the company reported a $36 million strategic investment by Cosmo Pharmaceuticals and U.S. rights to approved Travelers' diarrhea drug Aemcolo.
  • E*TRADE Financial Corp ETFC climbed 4% to $40.53 after the company reported better-than-expected Q3 EPS and sales results.


Check out these big penny stock gainers and losers

Losers

  • Gildan Activewear Inc. GIL shares dipped 20.9% to $28.00 after the company lowered its FY19 earnings guidance. Stifel Nicolaus downgraded the stock from Buy to Hold and lowered the price target from $44 to $30 per share.
  • Navios Maritime Acquisition Corporation NNA shares fell 20.7% to $8.28 after the company reported 1.88 million share offering of common stock at $8 per share.
  • Synthesis Energy Systems, Inc. SES fell 18.7% to $7.48 after rising 26.9% on Thursday.
  • Sensient Technologies Corporation SXT shares fell 11.9% to $58.60 after reporting downbeat Q3 results.
  • Mirati Therapeutics, Inc. MRTX dipped 11.9% to $76.72.
  • Hepion Pharmaceuticals, Inc. HEPA fell 11.7% to $3.1599 after rising 43.20% on Thursday.
  • HyreCar Inc. HYRE dipped 10.8% to $2.14.
  • McDermott International, Inc. MDR dropped 10.3% to $2.225.
  • Exponent, Inc. EXPO tumbled 9.3% to $64.25 following downbeat Q3 sales.
  • Slack Technologies, Inc. WORK dropped 9.3% to $21.78.
  • Can-Fite BioPharma Ltd. CANF shares declined 8.4% to $2.29.
  • L Brands, Inc. LB fell 8.1% to $16.64 after Credit Suisse downgraded the company's stock from Neutral to Underperform and lowered the price target from $22 to $14.
  • Jumia Technologies AG JMIA dropped 7.4% to $7.39 as a potential sell-off after the stock rallied roughly 33% since Tuesday.
  • Signet Jewelers Limited SIG shares declined 7.3% to $14.68.
  • Stage Stores, Inc. SSI shares fell 6.5% to $2.0301.
  • Atlassian Corporation PLC TEAM dropped 6.4% to $114.76 after the company issued FY20 EPS guidance below analyst estimates.
  • The Gap, Inc. GPS fell 6% to $16.51 after Credit Suisse downgraded the company's stock from Neutral to Underperform and lowered the price target from $20 to $14.
  • Coca-Cola FEMSA, S.A.B. de C.V. KOF shares fell 5.4% to $57.93.
  • Pzena Investment Management, Inc PZN shares fell 4.5% to $8.14 after reporting Q3 results.
  • Macy's, Inc. M fell 4% to $15.15 after Credit Suisse downgraded the company's stock from Neutral to Underperform and lowered the price target from $19 to $12.
  • Johnson & Johnson JNJ dropped 4% to $130.81 after the company recalled 1 lot of baby powder due to trace levels of asbestos.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversTrading IdeasGeneralConsumer DiscretionaryDepartment StoresMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!